233 related articles for article (PubMed ID: 33795686)
21. Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies.
Rauen KA; Banerjee A; Bishop WR; Lauchle JO; McCormick F; McMahon M; Melese T; Munster PN; Nadaf S; Packer RJ; Sebolt-Leopold J; Viskochil DH
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):136-46. PubMed ID: 21495172
[TBL] [Abstract][Full Text] [Related]
22. Cardio-facio-cutaneous syndrome: does genotype predict phenotype?
Allanson JE; Annerén G; Aoki Y; Armour CM; Bondeson ML; Cave H; Gripp KW; Kerr B; Nystrom AM; Sol-Church K; Verloes A; Zenker M
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):129-35. PubMed ID: 21495173
[TBL] [Abstract][Full Text] [Related]
23. A cardio-facio-cutaneous syndrome case with tight Achilles tendons.
Hazan F; Aykut A; Hizarcioglu M; Tavli V; Onay H; Ozkinay F
Genet Couns; 2012; 23(2):305-11. PubMed ID: 22876591
[TBL] [Abstract][Full Text] [Related]
24. Epilepsy in RAS/MAPK syndrome: two cases of cardio-facio-cutaneous syndrome with epileptic encephalopathy and a literature review.
Adachi M; Abe Y; Aoki Y; Matsubara Y
Seizure; 2012 Jan; 21(1):55-60. PubMed ID: 21871821
[TBL] [Abstract][Full Text] [Related]
25. Deletion of MAP2K2/MEK2: a novel mechanism for a RASopathy?
Nowaczyk MJ; Thompson BA; Zeesman S; Moog U; Sanchez-Lara PA; Magoulas PL; Falk RE; Hoover-Fong JE; Batista DA; Amudhavalli SM; White SM; Graham GE; Rauen KA
Clin Genet; 2014 Feb; 85(2):138-46. PubMed ID: 23379592
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular spectra of BRAF-associated RASopathy.
Lee Y; Choi Y; Seo GH; Kim GH; Choi IH; Keum C; Ko JM; Cheon CK; Jeon J; Choi JH; Yoo HW; Lee BH
J Hum Genet; 2021 Apr; 66(4):389-399. PubMed ID: 33040082
[TBL] [Abstract][Full Text] [Related]
27. Craniofacial and dental development in cardio-facio-cutaneous syndrome: the importance of Ras signaling homeostasis.
Goodwin AF; Oberoi S; Landan M; Charles C; Groth J; Martinez A; Fairley C; Weiss LA; Tidyman WE; Klein OD; Rauen KA
Clin Genet; 2013 Jun; 83(6):539-44. PubMed ID: 22946697
[TBL] [Abstract][Full Text] [Related]
28. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
[TBL] [Abstract][Full Text] [Related]
29. An adult case of cardiofaciocutaneous syndrome with BRAF mutation.
Sato S; Hida T; Okura M; Ishikawa A; Yamashita T
Eur J Dermatol; 2017 Aug; 27(4):412-413. PubMed ID: 28524057
[No Abstract] [Full Text] [Related]
30. Brain structural changes in patients with cardio-facio-cutaneous syndrome: effects of BRAF gene mutation and epilepsy on brain development. A case-control study by quantitative magnetic resonance imaging.
Calandrelli R; Pilato F; Panfili M; Battaglia D; Gambardella ML; Colosimo C
Neuroradiology; 2022 Jan; 64(1):185-195. PubMed ID: 34309696
[TBL] [Abstract][Full Text] [Related]
31. Skeletal muscle pathology in Costello and cardio-facio-cutaneous syndromes: developmental consequences of germline Ras/MAPK activation on myogenesis.
Tidyman WE; Lee HS; Rauen KA
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):104-14. PubMed ID: 21495178
[TBL] [Abstract][Full Text] [Related]
32. Fibrous dysplasia in cardio-facio-cutaneous syndrome: A case report and review of literature.
Dong X; Png NCY; Fortier MV; Lim JY; Wong KPL; Choo JTL; Tan EC; Jamuar SS
Am J Med Genet A; 2022 Sep; 188(9):2732-2737. PubMed ID: 35801299
[TBL] [Abstract][Full Text] [Related]
33. Nevus cells of cardiofaciocutaneous syndrome bear BRAF germ-line and somatic double mutations.
Hida T; Sato S; Okura M; Uhara H
Eur J Dermatol; 2018 Oct; 28(5):704-705. PubMed ID: 30406758
[No Abstract] [Full Text] [Related]
34. Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish.
Anastasaki C; Rauen KA; Patton EE
Dis Model Mech; 2012 Jul; 5(4):546-52. PubMed ID: 22301711
[TBL] [Abstract][Full Text] [Related]
35. Status epilepticus in BRAF-related cardio-facio-cutaneous syndrome: Focus on neuroimaging clues to physiopathology.
Musto E; Gambardella ML; Perulli M; Quintiliani M; Veredice C; Verdolotti T; Berté G; Leoni C; Onesimo R; Pulitanò SM; Tartaglia M; Zampino G; Contaldo I; Battaglia DI
Epilepsia Open; 2024 Feb; 9(1):258-267. PubMed ID: 37943120
[TBL] [Abstract][Full Text] [Related]
36. MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma.
Haston S; Pozzi S; Carreno G; Manshaei S; Panousopoulos L; Gonzalez-Meljem JM; Apps JR; Virasami A; Thavaraj S; Gutteridge A; Forshew T; Marais R; Brandner S; Jacques TS; Andoniadou CL; Martinez-Barbera JP
Development; 2017 Jun; 144(12):2141-2152. PubMed ID: 28506993
[TBL] [Abstract][Full Text] [Related]
37. Non-hodgkin lymphoma in a patient with cardiofaciocutaneous syndrome.
Ohtake A; Aoki Y; Saito Y; Niihori T; Shibuya A; Kure S; Matsubara Y
J Pediatr Hematol Oncol; 2011 Dec; 33(8):e342-6. PubMed ID: 20523244
[TBL] [Abstract][Full Text] [Related]
38. Impaired Osteogenesis of Disease-Specific Induced Pluripotent Stem Cells Derived from a CFC Syndrome Patient.
Choi JY; Han KM; Kim D; Lee BH; Yoo HW; Choi JH; Han YM
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194391
[TBL] [Abstract][Full Text] [Related]
39. Fetal autopsy findings of cardiofaciocutaneous syndrome with a unique BRAF mutation.
Terry J; Rauen KA; Nowaczyk MJ
Pediatr Dev Pathol; 2014; 17(1):59-63. PubMed ID: 24303953
[TBL] [Abstract][Full Text] [Related]
40. Alterations in RAS-MAPK genes in 200 Spanish patients with Noonan and other neuro-cardio-facio-cutaneous syndromes. Genotype and cardiopathy.
Ezquieta B; Santomé JL; Carcavilla A; Guillén-Navarro E; Pérez-Aytés A; Sánchez del Pozo J; García-Miñaur S; Castillo E; Alonso M; Vendrell T; Santana A; Maroto E; Galbis L
Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):447-55. PubMed ID: 22465605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
